Citations (134)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Shaghayegh Khanmohammadi & Nima Rezaei. (2023) CAR-NK cells: a promising cellular immunotherapy in lymphoma. Expert Opinion on Biological Therapy 23:1, pages 37-47.
Read now
Read now
Ibrahim Aldoss, Mary Clark, Guido Marcucci & Stephen J. Forman. (2021) Donor derived leukemia in allogeneic transplantation. Leukemia & Lymphoma 62:12, pages 2823-2830.
Read now
Read now
Maria Tavakoli-Ardakani, Narges Beyraghi, Mahtabalsadat Mirjalili, Ehsan Mirzaei & Maryam Mehrpooya. (2019) Effect of pretransplant depression on neutrophil recovery following hematopoietic stem cell transplantation. Transplant Research and Risk Management 11, pages 1-9.
Read now
Read now
Guido Kobbe, Thomas Schroeder, Christina Rautenberg, Jennifer Kaivers, Norbert Gattermann, Rainer Haas & Ulrich Germing. (2019) Molecular genetics in allogeneic blood stem cell transplantation for myelodysplastic syndromes. Expert Review of Hematology 12:10, pages 821-831.
Read now
Read now
Jennifer L. Hsu, Christian E. Bryant, Michael S. Papadimitrious, Benjamin Kong, Robin E. Gasiorowski, Daniel Orellana, Helen M. McGuire, Barbara Fazekas de St Groth, Douglas E. Joshua, P. Joy Ho, Stephen Larsen, Harry J. Iland, John Gibson, Georgina J. Clark, Phillip D. Fromm & Derek NJ Hart. (2018) A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remission. OncoImmunology 7:4.
Read now
Read now
Christan M. Thomas, Cindy Ippoliti, Gail J. Roboz, Eric Feldman, Dimitrios Savva, Sara James & Koen van Besien. (2017) Clofarabine as a bridge to hematopoietic stem cell transplant. Leukemia & Lymphoma 58:1, pages 230-232.
Read now
Read now
Szun Szun Tay, Hernan Carol & Maté Biro. (2016) TriKEs and BiKEs join CARs on the cancer immunotherapy highway. Human Vaccines & Immunotherapeutics 12:11, pages 2790-2796.
Read now
Read now
Houda Alachkar & Yusuke Nakamura. (2015) Deep-sequencing of the T-cell receptor repertoire in patients with haplo-cord and matched-donor transplants. Chimerism 6:3, pages 47-49.
Read now
Read now
Articles from other publishers (126)
Idoroenyi Amanam, Salman Otoukesh, Monzr M. Al Malki & Amandeep Salhotra. (2023) Chronic GVHD: review advances in prevention, novel endpoints, and targeted strategies. Hematology 2023:1, pages 164-170.
Crossref
Crossref
Pramath Kakodkar, Yayuan Zhao, Henry Pan, Fang Wu, Twyla Pearce, Destinie Webster, Mohamed Elemary, Waleed Sabry, Luvinia Kwan, Lindsay Pelzer, Mark Bosch, Karen R. Sherwood, James Lan, Jenny Tran, Robert Liwski, Paul Keown & Ahmed Mostafa. (2023) Validation of next-generation sequencing-based chimerism testing for accurate detection and monitoring of engraftment in hematopoietic stem cell transplantation. Frontiers in Genetics 14.
Crossref
Crossref
Muhammad Jamal, Yufei Lei, Hengjing He, Xingruo Zeng, Hina Iqbal Bangash, Di Xiao, Liang Shao, Fuling Zhou & Quiping Zhang. (2023) CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis. Frontiers in Pharmacology 14.
Crossref
Crossref
Lauren D. Scherer & Rayne H. Rouce. (2023) Targeted cellular therapy for treatment of relapsed or refractory leukemia. Best Practice & Research Clinical Haematology 36:3, pages 101481.
Crossref
Crossref
Ida Friberger, Joachim N. Nilsson, Li Lu, Jonathan Siikanen, Oscar Ardenfors, Stefan Milton, Erik Samén, Jeroen A. C. M. Goos, Mattias Carlsten, Staffan Holmin & Thuy A. Tran. (2023) Comparative in vivo biodistribution of cells labelled with [89Zr]Zr-(oxinate)4 or [89Zr]Zr-DFO-NCS using PET. EJNMMI Research 13:1.
Crossref
Crossref
Geothy Chakupurakal, Paul Freudenberger, Nicole Skoetz, Hans Ahr & Sebastian Theurich. (2023) Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults. Cochrane Database of Systematic Reviews 2023:6.
Crossref
Crossref
Esther Natalie Oliva, Anna Candoni, Prassede Salutari, Giuseppe A. Palumbo, Gianluigi Reda, Giuseppe Iannì, Giovanni Tripepi, Maria Cuzzola, Debora Capelli, Corrado Mammì, Caterina Alati, Maria Concetta Cannatà, Pasquale Niscola, Bianca Serio, Pellegrino Musto, Ernesto Vigna, Antonio Volpe, Lorella Maria Antonia Melillo, Maria Teresa Arcadi, Donato Mannina, Maria Elena Zannier & Roberto Latagliata. (2023) Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE). Cancers 15:9, pages 2441.
Crossref
Crossref
Madhuparna Nandi, Amit Ghosh, Sara Ali Akbari, Diwakar Bobbala, Marie-Josée Boucher, Alfredo Menendez, Trang Hoang, Subburaj Ilangumaran & Sheela Ramanathan. (2023) IL-15 Prevents the Development of T-ALL from Aberrant Thymocytes with Impaired DNA Repair Functions and Increased NOTCH1 Activation. Cancers 15:3, pages 671.
Crossref
Crossref
Mona Ali Hassan, Nour Moukalled, Jean El Cheikh, Ali Bazarbachi & Iman Abou Dalle. (2023) Azacitidine in Combination with Venetoclax Maintenance Post-allogeneic Hematopoietic Stem Cell Transplantation in T Cell Acute Lymphoblastic Leukemia. Clinical Hematology International 5:1, pages 52-55.
Crossref
Crossref
Ida Friberger, Vamsi Gontu, Robert A. Harris, Thuy A. Tran, Johan Lundberg & Staffan Holmin. (2023) Phenotyping of Macrophages After Radiolabeling and Safety of Intra-arterial Transplantation Assessed by SPECT/CT and MRI. Cell Transplantation 32.
Crossref
Crossref
Sanjeev Kumar SharmaSanjeev Kumar Sharma. 2023. Basics of Hematopoietic Stem Cell Transplant. Basics of Hematopoietic Stem Cell Transplant
551
570
.
Md. Junayed Hossain, Jannatul Ferdaus, Saifur Rahman & Sarmin Akter Santa. (2022) Multiclass Classification of GvHD and Relapse: A Comparative Analysis Among Machine Learning and ANN-based Algorithms. Multiclass Classification of GvHD and Relapse: A Comparative Analysis Among Machine Learning and ANN-based Algorithms.
Stephen M. Maurer, Kathleen A. Linder, Carol A. Kauffman, Philip J. McDonald, Jonathan Arcobello, Jon Velasco, Pranatharthi H. Chandrasekar, Sanjay G. Revankar & Marisa H. Miceli. (2022) Infectious complications after second allogeneic hematopoietic cell transplant in adult patients with hematological malignancies. Bone Marrow Transplantation 57:12, pages 1820-1826.
Crossref
Crossref
Maximilian Fleischmann, Sebastian Scholl, Jochen J. Frietsch, Inken Hilgendorf, Karin Schrenk, Jakob Hammersen, Florian Prims, Christian Thiede, Andreas Hochhaus & Ulf Schnetzke. (2022) Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia. Journal of Cancer Research and Clinical Oncology 148:11, pages 3191-3202.
Crossref
Crossref
Donghui Zhang & Jiahui Chen. (2022) Efficacy of decitabine combined with allogeneic hematopoietic stem cell transplantation in the treatment of recurrent and refractory acute myeloid leukemia (AML): A systematic review and meta-analysis. Medicine 101:37, pages e30644.
Crossref
Crossref
Viviane Gournay, Nicolas Vallet, Vivien Peux, Kristi Vera, Jennifer Bordenave, Marion Lambert, Aurélien Corneau, David Michonneau, Régis Peffault de Latour, Sophie Caillat-Zucman, Gérard Socié & Mathieu F. Chevalier. (2022) Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse. Blood 140:11, pages 1305-1321.
Crossref
Crossref
Sara Bolivar-Wagers, Michael L. Loschi, Sujeong Jin, Govindarajan Thangavelu, Jemma H. Larson, Cameron S. McDonald-Hyman, Ethan A. Aguilar, Asim Saha, Brent H. Koehn, Mehrdad Hefazi, Mark J. Osborn, Michael C. Jensen, John E. Wagner, Christopher A. Pennell & Bruce R. Blazar. (2022) Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses. JCI Insight 7:17.
Crossref
Crossref
Kevin X. Liu, Nicolas Poux, Kee-Young Shin, Nicholas Moore, Yu-Hui Chen, Steven Margossian, Jennifer S. Whangbo, Christine N. Duncan, Leslie E. Lehmann & Karen J. Marcus. (2022) Comparison of Pulmonary Toxicity after Total Body Irradiation- and Busulfan-Based Myeloablative Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients. Transplantation and Cellular Therapy 28:8, pages 502.e1-502.e12.
Crossref
Crossref
Miguel Waterhouse, Sandra Pennisi, Dietmar Pfeifer, Florian Scherer, Robert Zeiser, Justus Duyster, Hartmut Bertz, Jürgen Finke & Jesús Duque-Afonso. (2022) Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation. Cancers 14:14, pages 3307.
Crossref
Crossref
Sara Arabyarmohammadi, Patrick Leo, Vidya Sankar Viswanathan, Andrew Janowczyk, German Corredor, Pingfu Fu, Howard Meyerson, Leland Metheny & Anant Madabhushi. (2022) Machine Learning to Predict Risk of Relapse Using Cytologic Image Markers in Patients With Acute Myeloid Leukemia Posthematopoietic Cell Transplantation. JCO Clinical Cancer Informatics:6.
Crossref
Crossref
Luchen Sun, Jingyue Wang, Qiuping Wang, Zhonglei He, Tingzhe Sun, Yongfang Yao, Wenxin Wang & Pingping Shen. (2022) Pretreatment of umbilical cord derived MSCs with IFN-γ and TNF-α enhances the tumor-suppressive effect on acute myeloid leukemia. Biochemical Pharmacology 199, pages 115007.
Crossref
Crossref
Swati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, Manik Kuvalekar, Ayumi Watanabe, Catherine Robertson, Natalia Lapteva, Wang Tao, Mengfen Wu, Bambi Grilley, George Carrum, Rammurti T. Kamble, LaQuisa Hill, Robert A. Krance, Caridad Martinez, Priti Tewari, Bilal Omer, Stephen Gottschalk, Helen E. Heslop, Malcom K. Brenner, Cliona M. Rooney, Juan F. Vera, Ann M. Leen & Premal D. Lulla. (2022) Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL. Blood 139:17, pages 2706-2711.
Crossref
Crossref
Hannah Kinoshita, Kenneth R. CookeMelanie Grant, Maja StanojevicC. Russell CruzMichael KellerMaria Fernanda FortizFahmida HoqHaili Lang, A. John BarrettHua Liang, Jay TannaNan ZhangAbeer ShibliAnushree DatarKenneth FultonDivyesh KukadiyaAnqing ZhangKirsten M. Williams, Hema Dave, Jeffrey S. Dome, David JacobsohnPatrick J. HanleyRichard J. JonesCatherine M. Bollard. (2022) Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT. Blood Advances 6:8, pages 2520-2534.
Crossref
Crossref
Jesse M. Rappaport & Usman Ahmad. (2022) Commentary: Evidence over dogma: Lung transplant for posthematopoietic stem cell transplant related pulmonary failure. The Journal of Thoracic and Cardiovascular Surgery 163:4, pages 1559-1560.
Crossref
Crossref
Yoshitaka Adachi, Toshiyasu Sakai, Seitaro Terakura, Takashi Shiina, Shingo Suzuki, Hiroshi Hamana, Hiroyuki Kishi, Takehiko Sasazuki, Hisashi Arase, Ryo Hanajiri, Tatsunori Goto, Tetsuya Nishida, Makoto Murata & Hitoshi Kiyoi. (2022) Downregulation of HLA class II is associated with relapse after allogeneic stem cell transplantation and alters recognition by antigen-specific T cells. International Journal of Hematology 115:3, pages 371-381.
Crossref
Crossref
Judith Schaffrath, Tanja Diederichs, Susanne Unverzagt, Maxi Wass, Ulrike Gläser, Thomas Weber, Mascha Binder, Carsten Müller-Tidow & Lutz P. Müller. (2021) Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation. Annals of Hematology 101:3, pages 681-691.
Crossref
Crossref
Smith Kungwankiattichai, Ben Ponvilawan, Claudie Roy, Pattaraporn Tunsing, Florian Kuchenbauer & Weerapat Owattanapanich. (2022) Maintenance With Hypomethylating Agents After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis. Frontiers in Medicine 9.
Crossref
Crossref
Elias Mund, Johannes Salem, Hans H Kreipe & Kais Hussein. (2022) Clinically latent and autopsy-verified inflammatory disorders and malignant tumours in transplant patients. Journal of Clinical Pathology 75:2, pages 112-116.
Crossref
Crossref
Jennifer Marvin-Peek, Bipin N. Savani, Oluwole O. Olalekan & Bhagirathbhai Dholaria. (2022) Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia. Cancers 14:3, pages 497.
Crossref
Crossref
Nikola Lemajić, Milena Todorović-Balint & Nikola Peulić. (2022) Incidence and therapy of relapse after allogenic hematopoietic stem cell transplantation. Srpski medicinski casopis Lekarske komore 3:3, pages 334-345.
Crossref
Crossref
M. L. Dworkin, A. L. Jiang, R. Von Eyben, M. A. Spinner, R. H. Advani, R. Lowsky, S. M. Hiniker & R. T. Hoppe. (2021) Outcomes of adults with lymphoma treated with nonmyeloablative TLI-ATG and radiation boost to high risk or residual disease before allogeneic hematopoietic cell transplant. Bone Marrow Transplantation 57:1, pages 106-112.
Crossref
Crossref
Simona Jurkovic Mlakar, Satyanarayana Chakradhara Rao Uppugunduri, Tiago Nava, Vid Mlakar, Hadrien Golay, Shannon Robin, Nicolas Waespe, Mohamed Aziz Rezgui, Yves Chalandon, Jaap Jan Boelens, Robert G. M. Bredius, Jean-Hugues Dalle, Christina Peters, Selim Corbacioglu, Henrique Bittencourt, Maja Krajinovic & Marc Ansari. (2021) GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation. Journal of Cancer Research and Clinical Oncology 148:1, pages 71-86.
Crossref
Crossref
Khaled Sanber, Bipin Savani & Tania Jain. (2021)
Graft‐
versus
‐host disease risk after chimeric antigen receptor T‐cell therapy: the diametric opposition of T cells
. British Journal of Haematology 195:5, pages 660-668.
Crossref
Crossref
Ida Friberger, Emma Jussing, Jinming Han, Jeroen A. C. M. Goos, Jonathan Siikanen, Helen Kaipe, Mélanie Lambert, Robert A. Harris, Erik Samén, Mattias Carlsten, Staffan Holmin & Thuy A. Tran. (2021) Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications. Molecular Imaging and Biology 23:6, pages 952-962.
Crossref
Crossref
Andrius Zucenka, Vilmante Vaitekenaite, Kazimieras Maneikis, Linas Davainis, Regina Pileckyte, Igoris Trociukas, Valdas Peceliunas, Tadas Zvirblis, Vytautas Staras & Laimonas Griskevicius. (2021) Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation. Bone Marrow Transplantation 56:11, pages 2804-2812.
Crossref
Crossref
Deborah S. Hooker, Kristin Grabe-Heyne, Christof Henne, Peter Bader, Mondher Toumi & Stephen J. Furniss. (2021) Improved Therapeutic Approaches are Needed to Manage Graft-versus-Host Disease. Clinical Drug Investigation 41:11, pages 929-939.
Crossref
Crossref
Volkan Hazar, Gülyüz Öztürk, Koray Yalçın, Vedat Uygun, Serap Aksoylar, A. Küpesiz, İkbal Ok Bozkaya, Barbaros Şahin Karagün, Ceyhun Bozkurt, Talia İleri, Didem Atay, Ülker Koçak, Gülsün Tezcan Karasu, Akif Yeşilipek, Müge Gökçe, Savaş Kansoy, Gülen Tüysüz Kintrup, Musa Karakükcü, Fatma Visal Okur, Mehmet Ertem, Zühre Kaya, Orhan Gürsel, Yöntem Yaman, Namık Özbek, Bülent Antmen, Özlem Tüfekçi, Canan Albayrak, Başak Adaklı Aksoy, Gülay Sezgin, Davut Albayrak, Melike Sezgin Evim, Emine Zengin & Esra Pekpak. (2021) Different Kinetics and Risk Factors for Isolated Extramedullary Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Acute Leukemia. Transplantation and Cellular Therapy 27:10, pages 859.e1-859.e10.
Crossref
Crossref
Neal Shah, Kevin Rakszawski, Myles Nickolich, Christopher Ehmann, Baldeep Wirk, Seema Naik, Witold Rybka, Hong Zheng, Joseph Mierski, Brooke Silar, Gina Mackey, Robert Greiner, Valerie Brown, David Claxton, Shin Mineishi & Kentaro Minagawa. (2021) Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion. Annals of Hematology 100:10, pages 2585-2592.
Crossref
Crossref
Corrado Zuanelli Brambilla, Stephanie M. Lobaugh, Josel D. Ruiz, Parastoo B. Dahi, Aaron D. Goldberg, James W. Young, Boglarka Gyurkocza, Brian C. Shaffer, Doris M. Ponce, Roni Tamari, Miriam Sanchez Escamilla, Nerea Castillo Flores, Ioannis Politikos, Michael Scordo, Gunjan L. Shah, Christina Cho, Richard J. Lin, Molly A. Maloy, Sean M. Devlin, Ann A. Jakubowski, Ellin Berman, Eytan M. Stein, Esperanza B. Papadopoulos, Miguel-Angel Perales, Martin S. Tallman, Sergio A. Giralt & Melody Smith. (2021) Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy. Transplantation and Cellular Therapy 27:9, pages 771.e1-771.e10.
Crossref
Crossref
Lauren Bohannon, Helen Tang, Kristin Page, Yi Ren, Sin-Ho Jung, Alexandra Artica, Anne Britt, Prioty Islam, Sharareh Siamakpour-Reihani, Vinay Giri, Meagan Lew, Matthew Kelly, Taewoong Choi, Cristina Gasparetto, Gwynn Long, Richard Lopez, David Rizzieri, Stefanie Sarantopoulos, Nelson Chao, Mitchell Horwitz & Anthony Sung. (2021) Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies. Transplantation and Cellular Therapy 27:8, pages 669.e1-669.e8.
Crossref
Crossref
Xiaowen Tang, Benigno C. Valdez, Yunju Ma, Qianqian Zhang, Changju Qu, Haiping Dai, Jia Yin, Zheng Li, Ting Xu, Yang Xu, Jia Chen, Xiaming Zhu, Zixing Chen, Depei Wu & Borje S. Andersson. (2021) Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation 56:7, pages 1674-1682.
Crossref
Crossref
Claire L. Ruben, Filip Pirsl, Seth M. Steinberg, Noa G. Holtzman, Laura Parsons-Wandell, Judy Baruffaldi, Lauren M. Curtis, Sandra A. Mitchell, Ana Zelic Kerep, Edward W. Cowen, Ann Berger, Galen O. Joe, Manuel B. DatilesIIIIII, Jacqueline W. Mays & Steven Z. Pavletic. (2021) Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease. Bone Marrow Transplantation 56:7, pages 1584-1592.
Crossref
Crossref
Premal D. Lulla, Swati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, Ayumi Watanabe, Manik Kuvalekar, Suhasini Lulla, George Carrum, Carlos A. Ramos, Rammurti Kamble, LaQuisa Hill, Jasleen Randhawa, Stephen Gottschalk, Robert Krance, Tao Wang, Mengfen Wu, Catherine Robertson, Adrian P. Gee, Betty Chung, Bambi Grilley, Malcolm K. Brenner, Helen E. Heslop, Juan F. Vera & Ann M. Leen. (2021) Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. Blood 137:19, pages 2585-2597.
Crossref
Crossref
Jong-Bok Lee, Daniel Vasic, Hyeonjeong Kang, Karen Kai-Lin Fang & Li Zhang. (2021) State-of-Art of Cellular Therapy for Acute Leukemia. International Journal of Molecular Sciences 22:9, pages 4590.
Crossref
Crossref
Paula Muñiz, Mi Kwon, Diego Carbonell, María Chicano, Rebeca Bailén, Gillen Oarbeascoa, Julia Suárez-González, Cristina Andrés-Zayas, Javier Menárguez, Nieves Dorado, Ignacio Gómez-Centurión, Javier Anguita, José Luis Díez-Martín, Carolina Martínez-Laperche & Ismael Buño. (2021) Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide. Frontiers in Immunology 12.
Crossref
Crossref
Lee S. Nguyen, Lisa Raia, Bénédicte Lebrun-Vignes & Joe-Elie Salem. (2021) Graft Versus Host Disease Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Study and Systematic Literature Review. Frontiers in Pharmacology 11.
Crossref
Crossref
Fadi Haddad & Naval Daver. 2021. Immunotherapy. Immunotherapy
273
295
.
Jennifer N. Saultz. 2021. Blood and Marrow Transplant Handbook. Blood and Marrow Transplant Handbook
847
857
.
Diede van Ens, Charlotte M. Mousset, Tim J. A. Hutten, Anniek B. van der Waart, Diana Campillo-Davo, Sanne van der Heijden, Denise Vodegel, Hanny Fredrix, Rob Woestenenk, Loreto Parga-Vidal, Joop H. Jansen, Nicolaas P. M. Schaap, Eva Lion, Harry Dolstra & Willemijn Hobo. (2020) PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity. Bone Marrow Transplantation 55:12, pages 2308-2318.
Crossref
Crossref
Lisa Brice, Gemma McErlean, Caroline Donovan, Caley Tapp, Nicole Gilroy, Masura Kabir, Matt Greenwood, Stephen R. Larsen, John Moore, David Gottlieb, Mark Hertzberg, Louisa Brown, Megan Hogg, Gillian Huang, Jeff Tan, Christopher Ward & Ian Kerridge. (2020) Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional study. European Journal of Oncology Nursing 49, pages 101845.
Crossref
Crossref
Yue Lu, Yan-Li Zhao, Jian-Ping Zhang, Min Xiong, Xing-Yu Cao, De-Yan Liu, Rui-Juan Sun, Zhi-Jie Wei, Jia-Rui Zhou & Dao-Pei Lu. (2020) Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status. Annals of Hematology 99:12, pages 2911-2925.
Crossref
Crossref
Franziska M. Uhl, Sophia ChenDavid O’SullivanJoy Edwards-Hicks, Gesa Richter, Eileen Haring, Geoffroy Andrieux, Sebastian Halbach, Petya Apostolova, Jörg BüscherSandra DuquesneWolfgang MelchingerBarbara SauerKhalid Shoumariyeh, Annette Schmitt-Graeff, Marina Kreutz, Michael LübbertJustus Duyster, Tilman Brummer, Melanie Boerries, Tobias Madl, Bruce R. Blazar, Olaf Groß, Erika L. Pearce & Robert Zeiser. (2020) Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans. Science Translational Medicine 12:567.
Crossref
Crossref
Maryam Mehravar, Elham Roshandel, Maryam Salimi, Rouzbeh Chegeni, Majid Gholizadeh, Mohammad Hossein Mohammadi & Abbas Hajifathali. (2020) Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies. Immunology Letters 226, pages 71-82.
Crossref
Crossref
Hermioni L. Amonoo, Lydia A. Brown, Carlyn F. Scheu, Lauren E. Harnedy, William F. Pirl, Areej El‐Jawahri & Jeff C. Huffman. (2020) Beyond depression, anxiety and post‐traumatic stress disorder symptoms: Qualitative study of negative emotional experiences in hematopoietic stem cell transplant patients. European Journal of Cancer Care 29:5.
Crossref
Crossref
Jiafu Huang, Fen Huang, Zhiping Fan, Na Xu, Li Xuan, Hui Liu, Pengcheng Shi, Ling Jiang, Yu Zhang, Jing Sun & Qifa Liu. (2020) Haploidentical related donor vs matched sibling donor allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome aged over 50 years: A single‐center retrospective study. Cancer Medicine 9:17, pages 6244-6255.
Crossref
Crossref
Qi Chen, Xin Zhao, Hai-xia Fu, Yu-hong Chen, Yuan-yuan Zhang, Jing-zhi Wang, Yu Wang, Chen-hua Yan, Feng-rong Wang, Xiao-dong Mo, Wei Han, Huan Chen, Ying-jun Chang, Lan-ping Xu, Kai-yan Liu, Xiao-jun Huang & Xiao-hui Zhang. (2020) Comparison of central nervous system relapse outcomes following haploidentical vs identical-sibling transplant for acute lymphoblastic leukemia. Annals of Hematology 99:7, pages 1643-1653.
Crossref
Crossref
Lia Minculescu, Anne Fischer-Nielsen, Eva Haastrup, Lars Peter Ryder, Niels Smedegaard Andersen, Ida Schjoedt, Lone Smidstrup Friis, Brian Thomas Kornblit, Søren Lykke Petersen, Henrik Sengelov & Hanne Vibeke Marquart. (2020) Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation. Frontiers in Immunology 11.
Crossref
Crossref
Vincent T. Ho, Andrew St. Martin, Waleska S. Pérez, Patricia Steinert, Mei-Jie Zhang, Deborah Chirnomas, Caroline J. Hoang, Fausto R. LoberizaJr.Jr. & Wael Saber. (2020) Prior Gemtuzumab Ozogamicin Exposure in Adults with Acute Myeloid Leukemia Does Not Increase Hepatic Veno-Occlusive Disease Risk after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis. Biology of Blood and Marrow Transplantation 26:5, pages 884-892.
Crossref
Crossref
Shinto F. Thekkudan, Marcos Lima & Leland Metheny. (2019) Prevention of relapse after allogeneic stem cell transplantation in acute myeloid leukemia: Updates and challenges. ADVANCES IN CELL AND GENE THERAPY 3:2.
Crossref
Crossref
Mitchell Sabloff, Saurabh Chhabra, Tao Wang, Caitrin Fretham, Natasha Kekre, Allistair Abraham, Kehinde Adekola, Jeffery J. Auletta, Christopher Barker, Amer M. Beitinjaneh, Christopher Bredeson, Jean-Yves Cahn, Miguel Angel Diaz, Cesar Freytes, Robert Peter Gale, Siddhartha Ganguly, Usama Gergis, Eva Guinan, Betty K. Hamilton, Shahrukh Hashmi, Peiman Hematti, Gerhard Hildebrandt, Leona Holmberg, Sanghee Hong, Hillard M. Lazarus, Rodrigo Martino, Lori Muffly, Taiga Nishihori, Miguel-Angel Perales, Jean Yared, Shin Mineishi, Edward A. Stadtmauer, Marcelo C. Pasquini & Alison W. Loren. (2019) Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 25:12, pages 2398-2407.
Crossref
Crossref
Omotayo Fasan. (2019) Using minimal (measurable) residual disease assessments to guide decision-making for timing of allogeneic transplantation in acute myeloid leukemia. Current Opinion in Hematology 26:6, pages 413-420.
Crossref
Crossref
Elvira D’Ippolito, Kilian Schober, Magdalena Nauerth & Dirk H. Busch. (2019) T cell engineering for adoptive T cell therapy: safety and receptor avidity. Cancer Immunology, Immunotherapy 68:10, pages 1701-1712.
Crossref
Crossref
Jessica A. Langston, Vandana Sundaram, Vyjeyanthi S. Periyakoil & Lori Muffly. (2019) Healthcare Utilization is High in Adult Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 25:8, pages 1659-1665.
Crossref
Crossref
Attila Tordai, Andras Bors, Katalin Piroska Kiss, Katalin Balassa, Hajnalka Andrikovics, Arpad Batai, Aniko Szilvasi, Katalin Rajczy, Dora Inotai, Eva Torbagyi, Lilla Lengyel, Aniko Barta, Peter Remenyi & Tamas Masszi. (2019) Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning. PLOS ONE 14:6, pages e0218945.
Crossref
Crossref
Fotios V. Michelis, David W. Hedley, Sonal Malhotra, Sue Chow, David Loach, Vikas Gupta, Dennis D. Kim, John Kuruvilla, Jeffrey H. Lipton, Auro Viswabandya & Hans A. Messner. (2019) Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients with Acute Myelogenous Leukemia Undergoing Allografting: Assessment of Safety and Tolerability. Biology of Blood and Marrow Transplantation 25:6, pages 1158-1163.
Crossref
Crossref
A. M. Pilunov, A. A. Kuchmiy, S. A. Sheetikov, S. Y. Filkin, D. S. Romaniuk, F. N. Rosov & G. A. Efimov. (2019) Modification of Cytotoxic Lymphocytes with T Cell Receptor Specific for Minor Histocompatibility Antigen ACC-1Y. Molecular Biology 53:3, pages 402-410.
Crossref
Crossref
Richard J. Lin, Theresa A. Elko, Miguel-Angel Perales, Koshy Alexander, Ann A. Jakubowski, Sean M. Devlin, Parastoo B. Dahi, Esperanza B. Papadopoulos, Virginia M. Klimek, Sergio A. Giralt & Judith E. Nelson. (2018) End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer center. Bone Marrow Transplantation 54:5, pages 700-706.
Crossref
Crossref
Prachi Jain, Xin Tian, Stefan Cordes, Jinguo Chen, Caroline R. Cantilena, Christian Bradley, Reema Panjwani, Fariba Chinian, Keyvan Keyvanfar, Minoo Battiwalla, Pawel Muranski, A. John Barrett & Sawa Ito. (2019) Over-expression of PD-1 Does Not Predict Leukemic Relapse after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 25:2, pages 216-222.
Crossref
Crossref
Nabil Yafour, Marie Anne Couturier, Saba Azarnoush, Stéphane Girault, Eric Hermet, Stavroula Masouridi Levrat, Aline Schmidt, Mauricette Michallet, Pascaline Etancelin, Thierry Guillaume, Florent Malard, Anne Sirvent, Ibrahim Yakoub-Agha & Xavier Poiré. (2019) Seconde allogreffe : recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bulletin du Cancer 106:1, pages S40-S51.
Crossref
Crossref
Awais Ijaz, Ali Younas Khan, Saad Ullah Malik, Warda Faridi, Muhammad Asad Fraz, Muhammad Usman, Muhammad Junaid Tariq, Seren Durer, Ceren Durer, Atlantis Russ, Nadia Nunes Cavalcante Parr, Zeeshan Baig, FNU Sagar, Zeeshan Ali, Ali McBride & Faiz Anwer. (2019) Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation. Biology of Blood and Marrow Transplantation 25:1, pages 94-99.
Crossref
Crossref
Jasmine Zain, Merav Bar & Amar Safdar. 2019. Principles and Practice of Transplant Infectious Diseases. Principles and Practice of Transplant Infectious Diseases
227
247
.
M.P. Kawa, B. Baumert, Z. Litwińska, M. Gniot, E. Pius-Sadowska, D. Rogińska, K. Lewandowski, B. Zdziarska & B. Machaliński. (2018) Potential Leukemic Cells Engraftment After Hematopoietic Stem Cell Transplantation From Unrelated Donors With Undiagnosed Chronic Leukemia. Transplantation Proceedings 50:10, pages 3789-3796.
Crossref
Crossref
Athira Unnikrishnan, Amy M. Meacham, Steven S. Goldstein, Mai Ta, Helen L. Leather, Christopher R. Cogle, Paul Castillo, John R. Wingard & Maxim Norkin. (2018) CD34+ chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation. Leukemia Research 74, pages 110-112.
Crossref
Crossref
Christina Rautenberg, Sabrina Pechtel, Barbara Hildebrandt, Beate Betz, Ariane Dienst, Kathrin Nachtkamp, Mustafa Kondakci, Stefanie Geyh, Dagmar Wieczorek, Rainer Haas, Ulrich Germing, Guido Kobbe & Thomas Schroeder. (2018) Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 24:11, pages 2337-2343.
Crossref
Crossref
Bin Gu, Xiang Zhang, Guanghua Chen, Xiaojin Wu, Xiao Ma, Suning Chen & Depei Wu. (2018) Efficacy of haploidentical hematopoietic stem cell transplantation compared to HLA-matched transplantation for primary refractory acute myeloid leukemia. Annals of Hematology 97:11, pages 2185-2194.
Crossref
Crossref
Camila de Souza Meirelles & Rosa Wanda Diez-Garcia. (2018) Taste changes as a metaphor for biographical disruption: A qualitative study in patients undergoing haematopoietic stem cell transplantation. Clinical Nutrition ESPEN 27, pages 127-133.
Crossref
Crossref
Marcos de Lima, Betul Oran, Richard E. Champlin, Esperanza B. Papadopoulos, Sergio A. Giralt, Bart L. Scott, Basem M. William, Joel Hetzer, Eric Laille, Becky Hubbell, Barry S. Skikne & Charles Craddock. (2018) CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes. Biology of Blood and Marrow Transplantation 24:10, pages 2017-2024.
Crossref
Crossref
Juha Ranti, Samu Kurki, Urpu Salmenniemi, Mervi Putkonen, Soile Salomäki & Maija Itälä-Remes. (2018) Early CD8+-recovery independently predicts low probability of disease relapse but also associates with severe GVHD after allogeneic HSCT. PLOS ONE 13:9, pages e0204136.
Crossref
Crossref
Tom Fleischer, Tung-Ti Chang, Jen-Huai Chiang & Hung-Rong Yen. (2018) A Controlled Trial of Sheng-Yu-Tang for Post–Hematopoietic Stem Cell Transplantation Leukemia Patients: A Proposed Protocol and Insights From a Preliminary Pilot Study. Integrative Cancer Therapies 17:3, pages 665-673.
Crossref
Crossref
Zhiheng Cheng, Lei Zhou, Kai Hu, Yifeng Dai, Yifan Pang, Hongmian Zhao, Sun Wu, Tong Qin, Yu Han, Ning Hu, Li Chen, Chao Wang, Yijie Zhang, Depei Wu, Xiaoyan Ke, Jinlong Shi & Lin Fu. (2018) Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation 53:9, pages 1089-1095.
Crossref
Crossref
Jieun Kim, In Sik Hwang, Saeam Shin, Jong Rak Choi & Seung-Tae Lee. (2018) SNP-based next-generation sequencing reveals low-level mixed chimerism after allogeneic hematopoietic stem cell transplantation. Annals of Hematology 97:9, pages 1731-1734.
Crossref
Crossref
Moniek A. de Witte, Dhifaf Sarhan, Zachary Davis, Martin Felices, Daniel A. Vallera, Peter Hinderlie, Julie Curtsinger, Sarah Cooley, John Wagner, Jurgen Kuball & Jeffrey S. Miller. (2018) Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy. Biology of Blood and Marrow Transplantation 24:6, pages 1152-1162.
Crossref
Crossref
Selami Koçak Toprak. (2018) Donor lymphocyte infusion in myeloid disorders. Transfusion and Apheresis Science 57:2, pages 178-186.
Crossref
Crossref
Amro M.S. El-Ghammaz & Mostafa K. El-Razzaz. (2018) Risk Factors Influencing Outcome of Acute Leukemia Patients Who Experience Relapse After Allogeneic Hematopoietic Stem-Cell Transplantation. Clinical Lymphoma Myeloma and Leukemia 18:4, pages e183-e190.
Crossref
Crossref
Li Fan, Saisai Zhao, Qian Yang, Jiali Tan, Chaojun Song & Hong Wu. (2017) Ternary cocktail nanoparticles for sequential chemo-photodynamic therapy. Journal of Experimental & Clinical Cancer Research 36:1.
Crossref
Crossref
Eolia Brissot, Myriam Labopin, Matthias Stelljes, Gerhard Ehninger, Rainer Schwerdtfeger, Jürgen Finke, Hans-Jochem Kolb, Arnold Ganser, Kerstin Schäfer-Eckart, Axel R. Zander, Donald Bunjes, Stephan Mielke, Wolfgang A. Bethge, Noël Milpied, Peter Kalhs, Igor-Woflgang Blau, Nicolaus Kröger, Antonin Vitek, Martin Gramatzki, Ernst Holler, Christoph Schmid, Jordi Esteve, Mohamad Mohty & Arnon Nagler. (2017) Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT. Journal of Hematology & Oncology 10:1.
Crossref
Crossref
Steven Naymagon, Leonard Naymagon, Serre-Yu Wong, Huaibin Mabel Ko, Anne Renteria, John Levine, Jean-Frederic Colombel & James Ferrara. (2017) Acute graft-versus-host disease of the gut: considerations for the gastroenterologist. Nature Reviews Gastroenterology & Hepatology 14:12, pages 711-726.
Crossref
Crossref
Maxim Norkin, Lakshmikanth Katragadda, Fei Zou, Sican Xiong, Myron Chang, Yunfeng Dai, Jack W. Hsu, Jan S. Moreb, Helen Leather, Hemant S. Murthy, Nosha Farhadfar, Ying Li, Robert Hromas, Randy A. Brown, Christopher R. Cogle & John R. Wingard. (2017) Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia. Blood Cancer Journal 7:12.
Crossref
Crossref
Mohammad S. Hossain, Ghada M. Kunter, Vicky F. El-Najjar, David L. Jaye, Zaid Al-Kadhimi, Owonikoko K. Taofeek, Jian-Ming Li & Edmund K. Waller. (2017) PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients. PLOS ONE 12:9, pages e0184254.
Crossref
Crossref
Vedat Uygun, Hayriye Daloglu, Seda Öztürkmen, Gulsun Karasu & Akif Yesilipek. (2017) Three relapses after a haploidentical transplantation in a pediatric patient: Cure with no further transplantation. Pediatric Transplantation 21:6, pages e13005.
Crossref
Crossref
Johan M.J. Van den Bergh, Evelien L.J.M. Smits, Zwi N. Berneman, Tim J.A. Hutten, Hans De Reu, Viggo F.I. Van Tendeloo, Harry Dolstra, Eva Lion & Willemijn Hobo. (2017) Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion. Cancer Immunology Research 5:8, pages 710-715.
Crossref
Crossref
Noga Shem-Tov, Francesco Saraceni, Ivetta Danylesko, Roni Shouval, Ronit Yerushalmi, Arnon Nagler & Avichai Shimoni. (2017) Isolated Extramedullary Relapse of Acute Leukemia after Allogeneic Stem Cell Transplantation: Different Kinetics and Better Prognosis than Systemic Relapse. Biology of Blood and Marrow Transplantation 23:7, pages 1087-1094.
Crossref
Crossref
Bercelin Maniangou, Nolwenn Legrand, Mehdi Alizadeh, Ulysse Guyet, Catherine Willem, Gaëlle David, Eric Charpentier, Alexandre Walencik, Christelle Retière & Katia Gagne. (2017) Killer Immunoglobulin-Like Receptor Allele Determination Using Next-Generation Sequencing Technology. Frontiers in Immunology 8.
Crossref
Crossref
Y-R Ma, L-P Xu, X-H Zhang, C-H Yan, Y Wang, F-R Wang, J-Z Wang, Y Chen, W Han, Y-H Chen, H Chen, K-Y Liu & X-J Huang. (2016) Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantation. Bone Marrow Transplantation 52:3, pages 409-414.
Crossref
Crossref
J C Albring, S Inselmann, T Sauer, C Schliemann, B Altvater, S Kailayangiri, C Rössig, W Hartmann, J R Knorrenschild, K Sohlbach, C Groth, M Lohoff, A Neubauer, W E Berdel, A Burchert & M Stelljes. (2016) PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation. Bone Marrow Transplantation 52:2, pages 317-320.
Crossref
Crossref
Christine Neuchel, Daniel Fürst, Dietger Niederwieser, Donald Bunjes, Chrysanthi Tsamadou, Gerald Wulf, Michael Pfreundschuh, Eva Wagner, Gernot Stuhler, Hermann Einsele, Hubert Schrezenmeier & Joannis Mytilineos. (2017) Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors—A Retrospective Study. PLOS ONE 12:1, pages e0169512.
Crossref
Crossref
Shatha Farhan, Michael Bazydlo, Klodiana Neme, Nancy Mikulandric, Edward Peres & Nalini Janakiraman. (2017) Chimerism in Myeloid Malignancies following Stem Cell Transplantation Using FluBu4 with and without Busulfan Pharmacokinetics versus BuCy. Advances in Hematology 2017, pages 1-7.
Crossref
Crossref
Zachariah DeFilipp & Yi-Bin Chen. (2016) Strategies and Challenges for Pharmacological Maintenance Therapies after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 22:12, pages 2134-2140.
Crossref
Crossref
A M Brunner, A T Fathi & Y B Chen. (2016) Life after transplant: are we becoming high maintenance in AML?. Bone Marrow Transplantation 51:11, pages 1423-1430.
Crossref
Crossref
Jessica Gorgeis, Xu Zhang, Katelin Connor, Stacey Brown, Scott R. Solomon, Lawrence E. Morris, H. Kent Holland, Asad Bashey & Melhem Solh. (2016) T Cell–Replete HLA Haploidentical Donor Transplantation with Post-Transplant Cyclophosphamide Is an Effective Salvage for Patients Relapsing after an HLA-Matched Related or Matched Unrelated Donor Transplantation. Biology of Blood and Marrow Transplantation 22:10, pages 1861-1866.
Crossref
Crossref
Silvia Park, Kihyun Kim, Jun Ho Jang, Seok Jin Kim, Won Seog Kim & Chul Won Jung. (2016) Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantation. Oncotarget 7:37, pages 59892-59901.
Crossref
Crossref
Anil ChauhanNauroze A. FaiziYin Jie ChenLisa P. JonesNaveen GargPriya R. Bhosale. (2016) Role of Ultrasound in Complications of Hematopoetic Stem Cell Transplantation. Ultrasound Quarterly 32:3, pages 212-223.
Crossref
Crossref
D Bobbala, R Kandhi, X Chen, M Mayhue, E Bouchard, J Yan, H Knecht, F Barabé, S Ramanathan & S Ilangumaran. (2016) Interleukin-15 deficiency promotes the development of T-cell acute lymphoblastic leukemia in non-obese diabetes mice with severe combined immunodeficiency. Leukemia 30:8, pages 1749-1752.
Crossref
Crossref
M Solh, X Zhang, K Connor, S Brown, S R Solomon, L E Morris, H K Holland & A Bashey. (2016) Post-relapse survival after haploidentical transplantation vs matched-related or matched-unrelated hematopoietic cell transplantation. Bone Marrow Transplantation 51:7, pages 949-954.
Crossref
Crossref
M Byrne & B N Savani. (2016) The devil is in the T cells: relapsing after haploidentical hematopoietic cell transplantation. Bone Marrow Transplantation 51:7, pages 915-918.
Crossref
Crossref
Dean A. Lee, Cecele J. Denman, Gabriela Rondon, Glenda Woodworth, Julianne Chen, Tobi Fisher, Indreshpal Kaur, Marcelo Fernandez-Vina, Kai Cao, Stefan Ciurea, Elizabeth J. Shpall & Richard E. Champlin. (2016) Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial. Biology of Blood and Marrow Transplantation 22:7, pages 1290-1298.
Crossref
Crossref
Ibraheem H. Motabi, Armin Ghobadi, Jingxia Liu, Mark Schroeder, Camille N. Abboud, Amanda F. Cashen, Keith E. Stockler-Goldstein, Geoffrey L. Uy, Ravi Vij, Peter Westervelt & John F. DiPersio. (2016) Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant. Biology of Blood and Marrow Transplantation 22:7, pages 1324-1329.
Crossref
Crossref
Xiaowen Tang, Yao-Hua Song, Aining Sun, Xiaming Zhu, Changgeng Ruan & Depei Wu. (2016) Successful Treatment of Relapsed Acute Myeloid Leukemia Without Chemotherapy. Journal of Clinical Oncology 34:13, pages e117-e119.
Crossref
Crossref
Sophie Haro, Aude Tavenard, Fanny Rialland, Sophie Taque, Gaelle Guillerm, Pascale Blouin, Maxime Esvan, Isabelle Pellier & Virginie Gandemer. (2016) Keep in Mind Quality of Life: Outcome of a Ten-Year Series of Post-Transplantation Early Relapses in Childhood Acute Lymphoblastic Leukemia—A Report from the Grand Ouest Oncology Study Group for Children in France. Biology of Blood and Marrow Transplantation 22:5, pages 889-894.
Crossref
Crossref
Rosy Dabas, Rachelle Lee, Maria Theresa Servito, Poonam Dharmani-Khan, Monica Modi, Tiffany van Slyke, Joanne Luider, Caylib Durand, Loree Larratt, Joseph Brandwein, Don Morris, Andrew Daly, Faisal M. Khan & Jan Storek. (2016) Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic Blasts. Biology of Blood and Marrow Transplantation 22:5, pages 815-824.
Crossref
Crossref
Brian C. Shaffer, Jean-Benoit Le Luduec, Christopher Forlenza, Ann A. Jakubowski, Miguel-Angel Perales, James W. Young & Katharine C. Hsu. (2016) Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 22:4, pages 705-709.
Crossref
Crossref
Neethu N. Menon, Lydia M. Jenkins, Haiyan Cui, Craig Jenkins, Faiz Anwer, Andrew M. Yeager & Emmanuel Katsanis. (2016) Factors associated with improved outcomes after second allogeneic hematopoietic cell transplantation for relapsed pediatric leukemia. Annals of Hematology 95:4, pages 637-644.
Crossref
Crossref
P Y Yew, H Alachkar, R Yamaguchi, K Kiyotani, H Fang, K L Yap, H T Liu, A Wickrema, A Artz, K van Besien, S Imoto, S Miyano, M R Bishop, W Stock & Y Nakamura. (2015) Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplantation 50:9, pages 1227-1234.
Crossref
Crossref
Silvia Park, Kihyun Kim, Jun Ho Jang, Seok Jin Kim, Won Seog Kim, Eun-Suk Kang & Chul Won Jung. (2015) KIR alloreactivity based on the receptor–ligand model is associated with improved clinical outcomes of allogeneic hematopoietic stem cell transplantation: Result of single center prospective study. Human Immunology 76:9, pages 636-643.
Crossref
Crossref
Aleksandar Radujkovic, Cesare Guglielmi, Stefania Bergantini, Simona Iacobelli, Anja van Biezen, Dragana Milojkovic, Alois Gratwohl, Antonius V.M.B. Schattenberg, Leo F. Verdonck, Dietger W. Niederwieser, Theo de Witte, Nicolaus Kröger & Eduardo Olavarria. (2015) Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?. Biology of Blood and Marrow Transplantation 21:7, pages 1230-1236.
Crossref
Crossref
M Goswami, K S McGowan, K Lu, N Jain, J Candia, N F Hensel, J Tang, K R Calvo, M Battiwalla, A J Barrett & C S Hourigan. (2015) A multigene array for measurable residual disease detection in AML patients undergoing SCT. Bone Marrow Transplantation 50:5, pages 642-651.
Crossref
Crossref
T Sauer, G Silling, C Groth, F Rosenow, U Krug, D Görlich, G Evers, J Albring, R Besoke, R M Mesters, C Müller-Tidow, T Kessler, T Büchner, W E Berdel & M Stelljes. (2015) Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT. Bone Marrow Transplantation 50:4, pages 485-492.
Crossref
Crossref
A Rambaldi, E Biagi, C Bonini, A Biondi & M Introna. (2014) Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches. Leukemia 29:1, pages 1-10.
Crossref
Crossref
Houda Alachkar. 2015. Immunopharmacogenomics. Immunopharmacogenomics
103
113
.
Hugo Sousa, David Boutolleau, Joana Ribeiro, Ana L. Teixeira, Carlos Pinho Vaz, Fernando Campilho, Rosa Branca, António Campos Jr, Inês Baldaque & Rui Medeiros. (2014) Cytomegalovirus Infection in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation in Portugal: A Five-Year Retrospective Review. Biology of Blood and Marrow Transplantation 20:12, pages 1958-1967.
Crossref
Crossref
Elise B. Button, Nicole C. Gavin & Samantha J. Keogh. (2014) Exploring Palliative Care Provision for Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Who Relapsed. Oncology Nursing Forum 41:4, pages 370-381.
Crossref
Crossref
Katharine E. Adelstein, Joel G. Anderson & Ann Gill Taylor. (2014) Importance of Meaning-Making for Patients Undergoing Hematopoietic Stem Cell Transplantation. Oncology Nursing Forum 41:2, pages E172-E184.
Crossref
Crossref
Raymund Buhmann, Stanglmaier Michael, Hess Juergen, Lindhofer Horst, Christian Peschel & Hans-Jochem Kolb. (2013) Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial. Journal of Translational Medicine 11:1.
Crossref
Crossref
Z A McIver, F Yin, T Hughes, M Battiwalla, S Ito, E Koklanaris, J Haggerty, N F Hensel & A John Barrett. (2013) Second hematopoietic SCT for leukemia relapsing after myeloablative T cell-depleted transplants does not prolong survival. Bone Marrow Transplantation 48:9, pages 1192-1197.
Crossref
Crossref
Hee Won Chueh, Soo Hyun Lee, Ki Woong Sung, Keon Hee Yoo & Hong Hoe Koo. (2013) Second Allogeneic Stem Cell Transplantation in Hematologic Malignancies. Journal of Pediatric Hematology/Oncology 35:6, pages 424-429.
Crossref
Crossref
Christopher S. Hourigan & Judith E. Karp. (2013) Minimal residual disease in acute myeloid leukaemia. Nature Reviews Clinical Oncology 10:8, pages 460-471.
Crossref
Crossref